Physician

James Coggan, D.O.

According to 2025 Medicare claims, James Coggan, D.O. (NPI: 1508246042) practices medical oncology in the San Diego-Chula Vista-Carlsbad, CA market, with the plurality of this provider's patient population coming from San Diego, CA. This provider's primary affiliated billing organization is MEDICAL ONCOLOGY ASSOCIATES OF SAN DIEGO A MEDICAL GROUP INC (NPI: 1629046925; TIN: 330590652) and primary practice location at 92123-2773. Coggan is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Coggan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 298 traditional Medicare patients, billed 142,884 HCPCS/CPT codes, and received $2,814,658 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 539 prescription claims across 93 beneficiaries totaling $1,485,994 in drug costs, led by Brukinsa (Zanubrutinib). Open Payments data shows 4 records totaling $94,495. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,746 to $2,814,658. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,922 to $1,485,994. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.8M2018 Medicare payment: $3,746 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $8,609 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $433,642 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,843,587 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,814,658 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182425$3,746
20195456$8,609
2020N/RN/RN/R
2021N/RN/RN/R
202210527,775$433,642
2023257110,313$1,843,587
2024298142,884$2,814,658

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$743K$1.5M2015 Drug cost: $1,922 (USD; Tot_Drug_Cst)2016 Drug cost: $7,646 (USD; Tot_Drug_Cst)2017 Drug cost: $32,011 (USD; Tot_Drug_Cst)2018 Drug cost: $18,823 (USD; Tot_Drug_Cst)2019 Drug cost: $827 (USD; Tot_Drug_Cst)2022 Drug cost: $56,909 (USD; Tot_Drug_Cst)2023 Drug cost: $293,449 (USD; Tot_Drug_Cst)2024 Drug cost: $1,485,994 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151430$1,922
201630203$7,646
201742317$32,011
201813192$18,823
2019N/R29$827
2020N/RN/RN/R
2021N/RN/RN/R
20221740$56,909
202375396$293,449
202493539$1,485,994

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less56346$113
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4472$101
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less57144$53
96372Injection of drug or substance under skin or into muscle51201$12
36415Insertion of needle into vein for collection of blood sample194573$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BrukinsaZanubrutinib26780$392,104
TruqapCapivasertib11308$245,090
TagrissoOsimertinib Mesylate11330$185,969
XareltoRivaroxaban14660$11,475
EliquisApixaban17520$10,305

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.0$0N/R
Research PaymentsReported research-related payment or transfer-of-value amount.4$94,495Merck Sharp & Dohme LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for James Coggan, D.O.?

Tedicare shows public-source Medicare data for James Coggan, D.O. (NPI 1508246042), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Coggan, D.O. have ACO affiliation data?

James Coggan, D.O. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to James Coggan, D.O.?

James Coggan, D.O. is linked to MEDICAL ONCOLOGY ASSOCIATES OF SAN DIEGO A MEDICAL GROUP INC (billing NPI 1629046925) in the available physician profile data.

Does James Coggan, D.O. have Open Payments data?

James Coggan, D.O. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.